Condition

Kidney Cancers clinical trials and research

• 7Clinical trials
• 4Countries

Newest Kidney Cancers clinical trials

All recruiting trials (7)

• Can Gleolan help highlight kidney tumors during partial nephrectomy?

  This study tests whether giving Gleolan before kidney surgery helps fluorescence identify cancer tissue in adults with suspected kidney cancer undergoing partial nephrectomy.

  Recruiting Phase 2 Henry Ford Health System · Detroit, Michigan · NCT07828704

• Personalized 3D Tumoroids from Your Tumor to Test Treatments

  Researchers are using patient tumor tissue and blood to grow personalized 3D, vascularized tumoroids with autologous immune cells to help tailor treatments for kidney, bladder, and prostate cancers.

  Recruiting University Hospital, Strasbourg, France · Strasbourg · NCT07820566

• CAIX-targeted PET imaging to help diagnose kidney cancer

  This early-phase PET imaging study tests a CAIX-targeted tracer to see if it can help identify clear cell renal cell carcinoma in patients with kidney cancer.

  Recruiting Early Phase 1 Peking University Cancer Hospital & Institute · Beijing, Haidian · NCT07590310

• NEO-811 for advanced or metastatic clear cell kidney cancer

  This study will try the experimental oral drug NEO-811 in people with locally advanced or metastatic clear cell kidney cancer who have progressed on or refused standard treatments.

  Recruiting at 16 sites Phase 1 Neomorph, Inc · Duarte, California and 15 other locations · NCT07300241

• Abdominal CT offered alongside lung screening for people who have smoked

  We will test whether mentioning a possible extra abdominal CT in the lung screening invitation changes whether people aged 55–70 who have ever smoked attend their lung screening appointment.

  Recruiting University of Cambridge · Hull · NCT07171190

• Comprehensive pre-surgery conditioning, with or without planned preoperative cancer therapy, before major abdominal or pelvic cancer operations.

  This trial will test whether a comprehensive prehabilitation program, given alone or with planned neoadjuvant therapy, helps pre-frail or frail adults with pancreatic, ovarian, kidney, or bladder cancer better tolerate major cancer surgery.

  Recruiting Phase 2 The Methodist Hospital Research Institute · Houston, Texas · NCT07050771

• Targeted alpha therapy [212Pb]VMT-Alpha-NET for SSTR-positive metastatic or inoperable GI neuroendocrine, pheochromocytoma/paraganglioma, small cell lung, kidney, and head & neck cancers

  This trial will try an experimental targeted alpha-particle drug called [212Pb]VMT-Alpha-NET in adults whose metastatic or inoperable tumors show somatostatin receptor (SSTR) expression.

  Recruiting Phase 1 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT06479811

Related topics

Quick answers

How many Kidney Cancers clinical trials are recruiting right now?

7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 4 countries. The most sites are in United States (4 trials), United Kingdom (1 trial), France (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 2, Phase 2: 2, Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →